| Accession | SAMC1713924 |
|---|---|
| Accession in Other Database | GSA-Human: HRS180266 |
| Sample name | 180501819T3 |
| Title | none |
| Sample type | Human sample |
| Organism | Homo sapiens |
| Description | no |
| Attributes | *This sample record contains additional controlled-access information that is avaiable from GSA-Human by requesting study HRA000912 in the GSA-Human system. |
| Release date | 2021-06-10 |
| BioProject Accession | PRJCA005369 |
| Submitter | Xiaofan Zhu (xfzhu@ihcams.ac.cn) |
| Organization | Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College |
| Submission date | 2023-06-18 |
| Resource name | Description |
|---|---|
| GSA-Human (1) | - |
| HRA000912 (Controlled Access) | The aim of the study was to validate the diagnostic role of circulating tumor DNA (ctDNA) in genetics aberration on basis of next-generation sequencing (NGS) in pediatric acute myeloid leukemia (AML).Bone marrow (BM) and peripheral blood (PB) were collected from 20 AML children at the time of initial diagnosis, and ctDNA sample was isolated from PB. Detection of mutation was performed on ctDNA, BM and peripheral blood mononuclear cell (PBMC) by NGS based on a 185-gene panel. |